SYRCELT
Live / Registered — Registered (as of 10 Dec 2024)
What this means for you
Registered since 10 Dec 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79373376
- Registration number
- 7592418
- Mark type
- Stylized text
- Filed
- 07 Apr 2023
- Published for opposition
- 10 Sept 2024
- Registered
- 10 Dec 2024
- Attorney of record
- Bradley M. Stohry
Goods and services
- Class 001 — Chemicals: Chemical products for use in the pharmaceutical industry, namely, chemical additives and preservatives for use in the manufacture of pharmaceuticals; active chemical ingredients for manufacture of pharmaceutical products for treating cardiovascular, digestive, neurological, endocrine, respiratory, immune, muscular, urinary, reproductive, nutritional and skeletal diseases; chemical additives for use as binding agents in the manufacture of pharmaceuticals for treating cardiovascular, digestive, neurological, endocrine, respiratory, immune, muscular, urinary, reproductive, nutritional and skeletal diseases; chemical carrier excipients for use in the manufacture of pharmaceutical preparations; chemical excipients for the manufacture of pharmaceutical preparations; raw material, namely, cellulose microspheres and microspheres made of cellulose, sugar, and starch for use in the manufacture of pharmaceuticals; microcrystalline cellulose microspheres for use in the manufacture of pharmaceuticals; preserving agents for the pharmaceutical industry, namely, antioxidants and antimicrobials for use in the manufacture of pharmaceuticals; carrier excipients for use in the manufacture of pharmaceutical preparations; excipients for pharmaceutical preparation manufacture
- Class 005 — Pharmaceuticals: Pharmaceutical products, namely, syrups, preparations in the form of granules, and liquid pharmaceutical suspensions, for pharmaceutical purposes for the treatment of cardiovascular, digestive, neurological, endocrine, respiratory, immune, muscular, urinary, reproductive, nutritional and skeletal diseases, and pharmaceutical preparations for the treatment of cardiovascular, digestive, neurological, endocrine, respiratory, immune, muscular, urinary, reproductive, nutritional and skeletal diseases; medicines, namely, syrups, preparations in the form of granules, and liquid pharmaceutical suspensions, for pharmaceutical purposes for the treatment of cardiovascular, digestive, neurological, endocrine, respiratory, immune, muscular, urinary, reproductive, nutritional and skeletal diseases; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents, namely, medicine release agents in the form of gastro-resistant and controlled release microparticles for the controlled release of active ingredients for a wide range of pharmaceutical products; drug delivery agents, namely, medicine delivery agents in the form of granulated powders for the controlled release of active ingredients for a wide range of pharmaceutical products; syrups for pharmaceutical use for the treatment of cardiovascular, digestive, neurological, endocrine, respiratory, immune, muscular, urinary, reproductive, nutritional and skeletal diseases; syrups being medicines for the treatment of cardiovascular, digestive, neurological, endocrine, respiratory, immune, muscular, urinary, reproductive, nutritional and skeletal diseases; syringes pre-filled with syrups for the treatment of cardiovascular, digestive, neurological, endocrine, respiratory, immune, muscular, urinary, reproductive, nutritional and skeletal diseases; medicines being esomeprazole for oral administration; medicines being omeprazole for oral administration; central nervous system stimulants; hormones for medical use; Pharmaceutical products for the treatment of gastrointestinal disorders; soporifics
- Class 042 — Scientific and technological services: Pharmaceutical research and development for the pharmaceutical industry; medical and pharmacological research services; research and development services relating to medicines; development of pharmaceutical preparations and medicines; development of pharmaceutical products
Owner
Prosecution history
- 31 May 2025 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 11 May 2025 — FINAL DISPOSITION NOTICE SENT TO IB
- 11 May 2025 — FINAL DISPOSITION PROCESSED
- 10 Mar 2025 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 21 Dec 2024 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 10 Dec 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 10 Dec 2024 — REGISTERED-PRINCIPAL REGISTER
- 04 Dec 2024 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 04 Dec 2024 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 10 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Sept 2024 — PUBLISHED FOR OPPOSITION
- 21 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 07 Aug 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Aug 2024 — EXAMINER'S AMENDMENT ENTERED
- 07 Aug 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED